Pharma Equity Group A/S (PEG.CO)

DKK 0.18

(-2.17%)

Eps Summary of Pharma Equity Group A/S

  • Pharma Equity Group A/S's latest annual eps in 2023 was -0.02 DKK , down -124.44% from previous year.
  • Pharma Equity Group A/S's latest quarterly eps in 2024 Q2 was -0.01 DKK , up 18.57% from previous quarter.
  • Pharma Equity Group A/S reported an annual eps of 0.09 DKK in 2022, down -3.81% from previous year.
  • Pharma Equity Group A/S reported an annual eps of 0.10 DKK in 2021, up 109.42% from previous year.
  • Pharma Equity Group A/S reported a quarterly eps of -0.01 DKK for 2024 Q2, up 18.57% from previous quarter.
  • Pharma Equity Group A/S reported a quarterly eps of -0.01 DKK for 2023 Q4, down -195.35% from previous quarter.

Annual Eps Chart of Pharma Equity Group A/S (2023 - 2008)

Historical Annual Eps of Pharma Equity Group A/S (2023 - 2008)

Year Eps Eps Growth
2023 -0.02 DKK -124.44%
2022 0.09 DKK -3.81%
2021 0.10 DKK 109.42%
2020 -1.03 DKK -1356.86%
2019 -0.07 DKK 77.91%
2018 -0.32 DKK -4100.0%
2017 0.01 DKK 114.44%
2016 -0.06 DKK 57.38%
2015 -0.13 DKK 95.67%
2014 -3.00 DKK 96.79%
2013 -93.59 DKK -227.7%
2012 -28.56 DKK -133.14%
2011 -12.25 DKK -665.63%
2010 -1.60 DKK 88.7%
2009 -14.16 DKK 87.13%
2008 -109.99 DKK 0.0%

Peer Eps Comparison of Pharma Equity Group A/S

Name Eps Eps Difference
ALK-Abelló A/S 2.20 DKK 101.036%
Bavarian Nordic A/S 19.23 DKK 100.119%
Genmab A/S 66.64 DKK 100.034%
Gubra A/S -2.93 DKK 99.222%
Novo Nordisk A/S 18.67 DKK 100.122%
Orphazyme A/S -0.74 DKK 96.919%
Zealand Pharma A/S -12.44 DKK 99.817%